Drugs / EMLA cream
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06901271 | Mar 2018 → Jun 2019 | — | Aynur Aytekin Ozdemir | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06901271 ↗ |
| Route | Topical | “EMLA cream (2.5 grams) was applied to the treatment area” NCT06901271 ↗ |